Telehealth abortion with mifepristone continues, with backup plans still in place - Summary - MDSpire

Telehealth abortion with mifepristone continues, with backup plans still in place

  • By

  • Christine Henneberg

  • May 15, 2026

Share

Objective:

To discuss the implications of the Supreme Court ruling on telehealth access for mifepristone amid ongoing legal challenges.

Key Findings:
  • Telehealth medication abortion is as effective and safe as in-person care.
  • About 25% of abortions in the U.S. are now prescribed via telehealth, doubling since Roe v. Wade was overturned.
  • Mifepristone enhances the effectiveness of misoprostol, making the abortion process faster and easier.
Interpretation:

Restricting mifepristone access would interfere with the standard of care for patients and could lead to increased suffering for women seeking abortions.

Limitations:
  • The article does not provide comprehensive data on the long-term effects of alternative abortion methods.
  • Current alternatives like methotrexate and letrozole are not as effective or convenient as mifepristone.
Conclusion:

The ongoing legal battles over mifepristone access could significantly impact abortion care in the U.S., potentially reverting to less effective methods.

Original Source(s)

Related Content